journal£ºDiabetes Technology & Therapeutics
Authors£ºCarol J. Levy; Grenye O'Malley; Dan Raghinaru; Yogish C. Kudva; Lori M. Laffel; Jordan E. Pinsker; John W. Lum; Sue A. Brown; Boris Kovatchev; Stacey Anderson; Emma Emory; Mary Voelmle; Katie Conshafter; Kim Morris; Mary Oliveri; Linda Gondor-Fredrick; Harry Mitchell; Kayla Calvo; Christian Wakeman; Marc Breton; Elvira Isganaitis; Louise Ambler-Osborn; Emily Flint; Kenny Kim; Lindsay Roethke; Mei Mei Church; Camille Andre; Molly Piper; David Lam; Camilla Levister; Selassie Ogyaadu; Jessica Lovett; Vinaya Simha; Vikash Dadlani; Shelly McCrady-Spitzer; Corey Reid; Kanchan Kumari; R. Paul Wadwa; Greg Forlenza; G. Todd Alonso; Robert Slover; Emily Jost; Laurel Messer; Cari Berget; Lindsey Towers; Alex Rossick-Solis; Bruce Buckingham; Laya Ekhlaspour; Tali Jacobson; Marissa Town; Ideen Tabatabai; Jordan Keller; Evalina Salas; Francis Doyle; Eyal Dassau; Roy Beck; Samantha Passman; Tiffany Campos; Craig Kollman; Carlos Murphy; Nandan Patibandla; Sarah Borgman; Guillermo Arreaza-Rubin; Thomas Eggerman; Neal Green; Boris Kovatchev; Stacey Anderson; Marc Breton; R. Paul Wadwa; Bruce Buckingham; Francis Doyle; Eric Renard; Claudio Cobelli; Yves Reznik; Guillermo Arreaza-Rubin; Roy Beck; Robert Janicek; Deanna Gabrielson; Steven H. Belle; Jessica Castle; Jennifer Green; Laurent Legault; Steven M. Willi; Carol Wysham; Thomas Eggerman;
Published date£º2022-5-1
DOI£º10.1089/dia.2021.0431
Article link£ºhttp://dx.doi.org/10.1089/dia.2021.0431
Article Source£ºMary Ann Liebert Inc¡£
Remark£º |
10